Stathmin is a major cytosolic phosphoprotein that plays an important role i
n the regulation of microtubule dynamics during cell cycle progression. It
has recently been proposed that the major function of stathmin is to promot
e depolymerization of the microtubules that make up the mitotic spindle, In
this report, we tested the prediction that a deficiency in stathmin expres
sion would result in constitutive stabilization of microtubules and lead to
abnormalities in the organization of the mitotic spindle, Our studies demo
nstrate that antisense inhibition of stathmin expression in K562 erythroleu
kemic cells results in increased ratio of polymerized to depolymerized tubu
lin, These changes are associated with phenotypic abnormalities of the mito
tic spindle and difficulty in completing mitosis, These studies also showed
that inhibition of stathmin expression results in increased susceptibility
of K562 leukemic cells to the pharmacological agents, like taxol, which ar
e known to stabilize the mitotic spindle, In contrast, stathmin inhibition
results in decreased sensitivity to vinblastine, an agent that destabilizes
the mitotic spindle. Thus, our experimental findings are supportive of the
model that stathmin is a microtubule-destabilizing factor that plays an im
portant role in the regulation of the mitotic spindle. We also suggest a po
tential therapeutic approach for cancer based on the combination of stathmi
n inhibition with pharmacologic agents that stabilize the mitotic spindle.